These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15361952)

  • 21. Congenital Chagas' disease: diagnostic and clinical aspects.
    Freilij H; Altcheh J
    Clin Infect Dis; 1995 Sep; 21(3):551-5. PubMed ID: 8527542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute Chagas' disease: transmission routes, clinical aspects and response to specific therapy in diagnosed cases in an urban center].
    Shikanai-Yasuda MA; Lopes MH; Tolezano JE; Umezawa E; Amato Neto V; Barreto AC; Higaki Y; Moreira AA; Funayama G; Barone AA
    Rev Inst Med Trop Sao Paulo; 1990; 32(1):16-27. PubMed ID: 2124370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease.
    Sosa Estani S; Segura EL; Ruiz AM; Velazquez E; Porcel BM; Yampotis C
    Am J Trop Med Hyg; 1998 Oct; 59(4):526-9. PubMed ID: 9790423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent infections in chronic Chagas' disease patients treated with anti-Trypanosoma cruzi nitroderivatives.
    Braga MS; Lauria-Pires L; Argañaraz ER; Nascimento RJ; Teixeira AR
    Rev Inst Med Trop Sao Paulo; 2000; 42(3):157-61. PubMed ID: 10887376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of anti-B13 antibodies over time in a cohort of chronic infected by Trypanosoma cruzi. Its relationship with specific treatment and clinical status.
    Olivera V; Bizai ML; Arias E; Suasnabar S; Bottasso O; Marcipar I; Fabbro D
    Acta Trop; 2021 Jun; 218():105908. PubMed ID: 33789152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of complement mediated lysis technic in patients with chronic Chagas' disease treated with trypanocidal drugs].
    Levy AM; Pereira VL; Boainain E
    Rev Inst Med Trop Sao Paulo; 1988; 30(1):32-9. PubMed ID: 3146793
    [No Abstract]   [Full Text] [Related]  

  • 27. Pediatric clinical pharmacology studies in Chagas disease: focus on Argentina.
    Garcia-Bournissen F; Altcheh J; Giglio N; Mastrantonio G; Della Védova CO; Koren G
    Paediatr Drugs; 2009; 11(1):33-7. PubMed ID: 19127950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina.
    Sosa Estani S; Segura EL
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():363-5. PubMed ID: 10677756
    [No Abstract]   [Full Text] [Related]  

  • 29. Prospective, historically controlled study to evaluate the efficacy and safety of a new paediatric formulation of nifurtimox in children aged 0 to 17 years with Chagas disease one year after treatment (CHICO).
    Altcheh J; Castro L; Dib JC; Grossmann U; Huang E; Moscatelli G; Pinto Rocha JJ; Ramírez TE;
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008912. PubMed ID: 33412557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitrypanosomal therapy for chronic Chagas' disease.
    Bern C
    N Engl J Med; 2011 Jun; 364(26):2527-34. PubMed ID: 21714649
    [No Abstract]   [Full Text] [Related]  

  • 31. Current drug therapy and pharmaceutical challenges for Chagas disease.
    Bermudez J; Davies C; Simonazzi A; Real JP; Palma S
    Acta Trop; 2016 Apr; 156():1-16. PubMed ID: 26747009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of Trypanosoma cruzi infection in the indeterminate phase: experience and current guidelines in Argentina].
    Sosa Estani S; Segura EL
    Medicina (B Aires); 1999; 59 Suppl 2():166-70. PubMed ID: 10668259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission.
    Sosa-Estani S; Cura E; Velazquez E; Yampotis C; Segura EL
    Rev Soc Bras Med Trop; 2009; 42(5):484-7. PubMed ID: 19967227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern Argentina.
    Niborski LL; Grippo V; Lafón SO; Levitus G; García-Bournissen F; Ramirez JC; Burgos JM; Bisio M; Juiz NA; Ayala V; Coppede M; Herrera V; López C; Contreras A; Gómez KA; Elean JC; Mujica HD; Schijman AG; Levin MJ; Longhi SA
    Mem Inst Oswaldo Cruz; 2016 May; 111(6):365-71. PubMed ID: 27223650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chagas disease].
    Develoux M; Lescure FX; Le Loup G; Pialoux G
    Rev Med Interne; 2009 Aug; 30(8):686-95. PubMed ID: 19201068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity.
    Zingales B
    Acta Trop; 2018 Aug; 184():38-52. PubMed ID: 28941731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benznidazole treatment in chronic children infected with Trypanosoma cruzi: serological and molecular follow-up of patients and identification of Discrete Typing Units.
    Rumi MM; Pérez Brandán C; Gil JF; D'Amato AM; Ragone PG; Lauthier JJ; Tomasini N; Cimino RO; Orellana V; Lacunza CD; Nasser JR; Basombrío MA; Diosque P
    Acta Trop; 2013 Oct; 128(1):130-6. PubMed ID: 23880286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy of Chagas' disease: status and new developments.
    Cerecetto H; González M
    Curr Top Med Chem; 2002 Nov; 2(11):1187-213. PubMed ID: 12171581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Trypanosoma cruzi purified glycoprotein (GP57/51) or trypomastigote-shed antigens to assess cure for human Chagas' disease.
    Gazzinelli RT; Galvao LM; Krautz G; Lima PC; Cancado JR; Scharfstein J; Krettli AU
    Am J Trop Med Hyg; 1993 Nov; 49(5):625-35. PubMed ID: 8250103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nifurtimox chemotherapy: collateral effects in treated Trypanosoma cruzi infected patients.
    Murcia L; Carrilero B; Albajar Viñas P; Segovia M
    Rev Esp Quimioter; 2012 Mar; 25(1):74-5. PubMed ID: 22488545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.